Results 191 to 200 of about 1,972,524 (235)
Convalescent plasma for persistent symptomatic COVID-19 infection in immune-suppressed patients - a case series. [PDF]
Ronen D +6 more
europepmc +1 more source
Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
Our aim is to assess the prevalence and associated clinical features of anti-CCP (cyclic citrullinated peptide) antibodies for RF (rheumatoid factor)-positive and RF-negative rheumatoid arthritis (RA) and psoriatic arthritis (PsA). In a prospective, cross-sectional, multi-centre study, we determined the titres of anti-CCP antibodies in 208 RA patients (
Murat Inanç, S Kamali, N Inanç
exaly +8 more sources
Patients presenting with both arthralgia and antibodies to cyclic citrullinated peptide (anti-CCP) have an increased risk of developing rheumatoid arthritis (RA). To further characterise this patient group and shed more light on its relationship with clinically manifest early arthritis and established RA, an immunogenetic and serological analysis was ...
Bos, W. H. +11 more
openaire +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Anti-CCP biosensors in rheumatoid arthritis
Clinica Chimica ActaBiosensors are unique analytical tools for the detection of biomarkers. Of these, autoantibodies against citrullinated proteins (ACPA) are useful for the differential diagnosis of rheumatoid arthritis (RA). The autoantibodies may be detected by immunoassay technology using synthetic cyclic citrullinated peptides (CCP), ie, anti-CCP.
Pari Karami, Mohammad Johari-Ahar
exaly +3 more sources
Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper
Autoimmunity Reviews, 2010Rheumatoid arthritis (RA) is a crippling joint disease affecting over 20 million people worldwide. The cause of RA is most probably linked to the triad of microbial trigger, genetic association and autoimmunity and can be explained using the philosophical method of Karl Popper or Popperian sequences.
Alan Ebringer +2 more
exaly +4 more sources
Clinical Utility of the Anti-CCP Assay: Experiences with 700 Patients
Annals of the New York Academy of Sciences, 2005Abstract: Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in a series of patients with a variety of rheumatic diseases. Seven hundred consecutive serum samples from patients at an outpatient clinic were tested for the presence of rheumatoid factor (RF) and anti‐CCP.
Ulrich, Sauerland +8 more
exaly +3 more sources
High positivity of anti-CCP antibodies in patients with Down syndrome
Clinical Rheumatology, 2007The aim of the present study was to evaluate the prevalence of anti-cyclic citrullinated peptide (CCP) antibodies in patients with Down's syndrome (DS) previously tested for IgM rheumatoid factor (RF) and to correlate the results with clinical findings.
Nisihara R +2 more
exaly +3 more sources
Background: The detection of anti-cyclic citrullinated peptide (anti-CCP) IgG antibodies in blood is mainly used for the diagnosis of rheumatoid arthritis. Falsely elevated anti-CCP IgG antibodies due to anti-streptavidin IgG antibodies were suspected in
Mario Berth
exaly +2 more sources
Redefining the HLA and RA association: To be or not to be anti-CCP positive
Journal of Autoimmunity, 2005Rheumatoid Arthritis (RA) is the most common chronic inflammatory joint disease. The overall prevalence is 1% and in people older than 60 it is more than 2%. RA has auto-immune features: auto-antibodies against the Fc part of IgG, so-called Rheumatoid Factor (RF) are found more often in RA patients and more recently RA-specific auto-antibodies directed
René R P, de Vries +2 more
openaire +2 more sources

